Initial results of RETINA IMPLANT Alpha AMS trial published

The scientific journal "Frontiers in Neuroscience" has published a report on the functionality of Retina Implant AG’s RETINA IMPLANT Alpha AMS subretinal implant. The joint article by a group of experts headed by Eberhart Zrenner, Senior Professor of Ophthalmology at the Werner Reichardt Centre for Integrative Neuroscience, which forms part of the Institute for Ophthalmic Research at the Eberhard Karls University of Tübingen, relates to clinical experience with a group of patients who had the latest version of the chip implanted at various hospitals in Europe.

In the article, entitled “Interim Results of a Multicenter Trial with the New Electronic Subretinal Implant Alpha AMS in 15 Patients Blind from Inherited Retinal Degenerations”, lead author Dr. Katharina Stingl from the Tübingen Institute for Ophthalmic Research and other doctors and scientists involved in the trial describe how the chip performed.

Stingl K., Schippert R., Bartz-­Schmidt K. U., Besch D., Cottriall C. L., Edwards T. L., Gekeler F., Greppmaier U., Kiel K., Koitschev A., Kühlewein L., MacLaren R. E., Ramsden J. D., Roider J., Rothermel A., Sachs H., Schröder G. S., Tode J., Troelenberg N. and Zrenner E. (2017): Interim Results of a Multicenter Trial with the New Electronic Subretinal Implant Alpha AMS in 15 Patients Blind from Inherited Retinal Degenerations. Frontiers in Neuroscience. 11:445. doi: 10.3389/ fnins.2017.00445.

Open Access source find here: http://journal.frontiersin.org/article/10.3389/fnins.2017.00445/full